fidaxomicin,
lipiarmycin,
lipiarmycin A3,
lipiarmycin A4,
lipiarmycin B,
lipiarmycin B3,
lipiarmycin B4,
PAR 101,
PAR-101,
PAR101,
tiacumicin B,
tiacumicin C,
Fidaxomicin,
Dificid,
Lipiarmycin,
Tiacumicin B,
UNII-Z5N076G8YQ,
OPT-80,
Z5N076G8YQ,
Clostomicin B1,
Lipiarmycin A 3,
873857-62-6,
PAR-101,
Dificlir,
Difimicin,
Lipiarmycin A3,
R-Tiacumicin B,
BRN 5228707,
Fidaxomicin [USAN:INN],
PAR 01,
Clostomycin B1,
fidaxomicin/Dificid,
CHEMBL1255800,
SCHEMBL10000818,
Fidaxomicin, >=98% (HPLC),
FI8,
S-7827,
(2R,3S,4S,5S,6R)-6-{[(3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-{[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-[(2-methylpropanoyl)oxy]oxan-2-yl]oxy}-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy}-4-hydroxy-5-methoxy-2-methyloxan-3-yl 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate,
Lipiarmicin,
Dificid (TN),
Fidaxomicin [USAN],
D06LNW,
OPT 80,
PAR 101,
C52H74Cl2O18,
C52-H74-Cl2-O18,
CID10034073,
56645-60-4,